Immunomedics Inc
(IMMU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,229 | N/A | -43,210 | -29,189 | -15,416 |
| Depreciation Amortization | 513 | N/A | 1,659 | 1,130 | 570 |
| Other Working Capital | -1,870 | N/A | 2,743 | 4,258 | 584 |
| Other Operating Activity | 778 | 0 | 2,890 | 1,977 | 912 |
| Operating Cash Flow | $-16,808 | $N/A | $-35,918 | $-21,824 | $-13,350 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,712 | N/A | 35,271 | 23,379 | 12,292 |
| PPE Investments | -648 | N/A | -1,431 | -1,231 | -690 |
| Investing Cash Flow | $12,064 | $N/A | $33,840 | $22,148 | $11,602 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 105 | N/A | 158 | N/A | 142 |
| Other Financing Activity | -105 | 0 | -317 | -27 | -84 |
| Financing Cash Flow | $0 | $N/A | $-159 | $-27 | $59 |
| Exchange Rate Effect | 5 | N/A | -6 | -34 | 21 |
| Beginning Cash Position | 13,204 | N/A | 13,453 | 13,453 | 13,453 |
| End Cash Position | 8,465 | N/A | 11,209 | 13,716 | 11,785 |
| Net Cash Flow | $-4,739 | $N/A | $-2,244 | $263 | $-1,668 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,808 | N/A | -35,918 | -21,824 | -13,350 |
| Capital Expenditure | -648 | N/A | -1,431 | -1,231 | -690 |
| Free Cash Flow | -17,456 | 0 | -37,349 | -23,054 | -14,039 |